Peter E Buckley

Summary

Affiliation: Medical College of Georgia
Country: USA

Publications

  1. ncbi request reprint Lack of insight in schizophrenia: impact on treatment adherence
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, 1515 Pope Avenue, Augusta, Georgia 30912, USA
    CNS Drugs 21:129-41. 2007
  2. ncbi request reprint Neurotrophins and schizophrenia
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, Georgia 30912, United States
    Schizophr Res 94:1-11. 2007
  3. ncbi request reprint Strategies for dosing and switching antipsychotics for optimal clinical management
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 69:4-17. 2008
  4. ncbi request reprint Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Schizophr Res 79:281-8. 2005
  5. ncbi request reprint Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912, USA
    J Affect Disord 100:S33-43. 2007
  6. ncbi request reprint Olanzapine: a critical review of recent literature
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Expert Opin Pharmacother 6:2077-89. 2005
  7. ncbi request reprint Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 67:5-9. 2006
  8. ncbi request reprint First-episode schizophrenia. A window of opportunity for optimizing care and outcomes
    Peter E Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta 30912, USA
    Postgrad Med . 2006
  9. pmc Brain derived neurotropic factor in first-episode psychosis
    Peter F Buckley
    Department of Psychiatry and Health Behavior, School of Medicine, Medical College of Georgia, Augusta, GA 30912, USA
    Schizophr Res 91:1-5. 2007
  10. ncbi request reprint The history of the American Association of Chairs of Departments of Psychiatry
    Peter F Buckley
    Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912, USA
    Acad Psychiatry 31:97-8. 2007

Research Grants

Detail Information

Publications53

  1. ncbi request reprint Lack of insight in schizophrenia: impact on treatment adherence
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, 1515 Pope Avenue, Augusta, Georgia 30912, USA
    CNS Drugs 21:129-41. 2007
    ..The extent to which second-generation antipsychotic medications, including a recently released long-acting formulation, improve insight and/or enhance treatment adherence remains to be determined...
  2. ncbi request reprint Neurotrophins and schizophrenia
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, Georgia 30912, United States
    Schizophr Res 94:1-11. 2007
    ..This article reviews the literature on neurotrophins and schizophrenia. A schema for understanding the neurobiology of relapse in schizophrenia is offered...
  3. ncbi request reprint Strategies for dosing and switching antipsychotics for optimal clinical management
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 69:4-17. 2008
    ....
  4. ncbi request reprint Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Schizophr Res 79:281-8. 2005
    ..The extent of monitoring for metabolic adverse effects was low and inconsistent across measures and in frequency of evaluation. Ongoing efforts are needed to support and encourage change in clinician practice...
  5. ncbi request reprint Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912, USA
    J Affect Disord 100:S33-43. 2007
    ..Agitation and aggression are potentially disruptive and dangerous features of bipolar mania. This analysis evaluated the effects of quetiapine on agitation and aggression in patients with bipolar I mania...
  6. ncbi request reprint Olanzapine: a critical review of recent literature
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Expert Opin Pharmacother 6:2077-89. 2005
    ..New information continues to emerge on the impact of olanzapine on schizophrenia and on aspects of the course of mood disorders. There are also continued efforts to understand, predict and manage the side-effect risk with olanzapine...
  7. ncbi request reprint Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 67:5-9. 2006
    ....
  8. ncbi request reprint First-episode schizophrenia. A window of opportunity for optimizing care and outcomes
    Peter E Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta 30912, USA
    Postgrad Med . 2006
    ....
  9. pmc Brain derived neurotropic factor in first-episode psychosis
    Peter F Buckley
    Department of Psychiatry and Health Behavior, School of Medicine, Medical College of Georgia, Augusta, GA 30912, USA
    Schizophr Res 91:1-5. 2007
    ..Low BDNF levels at the onset of psychosis suggest that it may contribute to the pathogenesis of schizophrenia and/or perhaps could be a helpful neurobiological marker for possible early treatment intervention...
  10. ncbi request reprint The history of the American Association of Chairs of Departments of Psychiatry
    Peter F Buckley
    Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912, USA
    Acad Psychiatry 31:97-8. 2007
  11. ncbi request reprint Introduction: the art and science of switching antipsychotic medications
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 68:4. 2007
  12. ncbi request reprint Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta, GA 30912, USA
    J Clin Psychiatry 68:5-9. 2007
    ..An understanding of the differential receptor-binding profiles of the various antipsychotics can help clinicians anticipate and manage potential clinical issues that may be encountered when switching antipsychotic therapy...
  13. ncbi request reprint Factors that influence treatment success in schizophrenia
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912 3800, USA
    J Clin Psychiatry 69:4-10. 2008
    ..These factors can be conveniently grouped into 3 categories: treatment-related factors, patient-related factors, and environment- or system-related factors...
  14. doi request reprint Leadership and professional workforce development
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA, USA
    Psychiatr Clin North Am 31:105-22. 2008
    ..This article chronicles the trajectory of workforce development and professional growth in psychiatry...
  15. ncbi request reprint Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912 3800, USA
    Drugs Today (Barc) 41:5-11. 2005
    ..There is also a pressing need for additional information on the long-term efficacy and safety of each second-generation antipsychotic agent during maintenance therapy for bipolar disorders...
  16. ncbi request reprint A three-dimensional morphometric study of craniofacial shape in schizophrenia
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Ave, Augusta, GA 30912 3800, USA
    Am J Psychiatry 162:606-8. 2005
    ..Advances in facial visualization now allow for three-dimensional anthropometric evaluations of potentially greater discriminatory power in examining the complex geometric relationships of facial topography...
  17. ncbi request reprint When symptoms persist: clozapine augmentation strategies
    P Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta 30912, USA
    Schizophr Bull 27:615-28. 2001
    ..Current systematic efforts to enhance the treatment of these patients with adjunctive therapies are worthy of being studied in carefully conducted clinical trials...
  18. ncbi request reprint Treatment of the psychotic patient who is violent
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912 3800, USA
    Psychiatr Clin North Am 26:231-72. 2003
    ..Violence risk reduction is not only crucial from a societal perspective, but also it is a humanitarian necessity to alleviate the burden and stigma for patients with serious mental illness...
  19. ncbi request reprint Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912 3800, USA
    Drugs Today (Barc) 39:145-51. 2003
    ....
  20. ncbi request reprint Maintenance treatment for schizophrenia with quetiapine
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia, USA
    Hum Psychopharmacol 19:121-4. 2004
    ..04 for BPRS and 2.43 for CGI severity of illness. Although limited by patient attrition, these OLE data suggest that an initial beneficial response with quetiapine treatment can be maintained over a long-term period...
  21. ncbi request reprint Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA, USA
    Curr Med Res Opin 20:1357-63. 2004
    ..To determine the effectiveness of quetiapine (Seroquel) against specific aspects of schizophrenic symptomatology...
  22. ncbi request reprint Effective dosing and dose equivalency of second-generation antipsychotic medications
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta, GA 30912, USA
    CNS Spectr 9:24-31. 2004
    ..There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs...
  23. ncbi request reprint Insight and its relationship to violent behavior in patients with schizophrenia
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, 1515 Pope Ave, Augusta, GA 30912, USA
    Am J Psychiatry 161:1712-4. 2004
    ..Lack of insight affects the management of schizophrenia. The interrelationship between lack of insight and illness attributes in patients with schizophrenia who commit violent acts is important and underresearched...
  24. ncbi request reprint Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia
    Peter F Buckley
    Department of Psychiatry and Health Behavior Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912, USA
    Schizophr Res 66:143-50. 2004
    ..Weight gain was modest but more apparent in quetiapine-treated patients. Quetiapine is an appropriate treatment choice in patients who do not respond to prior antipsychotic treatment...
  25. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004
    ..This article reports the recommendations developed in 2002 and 2003 by a group of experts, clinicians, and administrators...
  26. ncbi request reprint The art and science of switching of antipsychotic medications, part 1
    Peter J Weiden
    Department of Psychiatry, Schizophrenia Research Program, State University of New York Downstate Medical Center, Brooklyn, USA
    J Clin Psychiatry 67:e15. 2006
    ....
  27. doi request reprint Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study
    Jayendra K Patel
    Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01605, USA
    Schizophr Res 111:9-16. 2009
    ..To further define the metabolic profiles of second-generation antipsychotics during the treatment of young patients with early psychosis, with a view to better inform prescribing clinicians...
  28. ncbi request reprint The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
    Troy A Moore
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA
    J Clin Psychiatry 68:1751-62. 2007
    ....
  29. ncbi request reprint Pharmacogenetics and schizophrenia
    Adriana Foster
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    Psychiatr Clin North Am 30:417-35. 2007
    ....
  30. ncbi request reprint Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism
    Del D Miller
    Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242 1000, USA
    Am J Med Genet B Neuropsychiatr Genet 133:97-100. 2005
    ..Subjects without the -759T variant allele were at a greater risk for weight gain from clozapine over 6-months compared to those with the -759T allele...
  31. ncbi request reprint Head size and schizophrenia
    Peter F Buckley
    Medical College of Georgia, Department of Psychiatry and Behavioral Health, 1515 Pope Avenue, Augusta, GA 30192 3800
    Schizophr Res 55:99-104. 2002
    ..Head size was found to be normal in schizophrenia. The relationship of brain size to head size is elaborated...
  32. ncbi request reprint Recovery and systems transformation for schizophrenia
    Scott A Peebles
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA 30912, USA
    Psychiatr Clin North Am 30:567-83. 2007
    ..This article reviews the growing literature regarding recovery, offers a conceptual framework for understanding recovery, and discusses a specific manner in which systems transformation has begun to occur...
  33. pmc Psychiatric comorbidities and schizophrenia
    Peter F Buckley
    Schizophr Bull 35:383-402. 2009
    ....
  34. ncbi request reprint Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia
    C Simon Sebastian
    Department of Psychiatry, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912, USA
    Curr Med Chem 11:329-42. 2004
    ..This review provides an account of representative studies for each second generation antipsychotic, which illustrate the contributions of naturalistic studies to our understanding of the evolving pharmacotherapy of schizophrenia...
  35. ncbi request reprint The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone
    Peter F Buckley
    Medical College of Georgia, United States
    Schizophr Res 94:99-106. 2007
    ....
  36. doi request reprint Pharmacotherapy for treatment-refractory schizophrenia
    Scott P Van Sant
    Medical College of Georgia, Department of Psychiatry and Health Behavior, Augusta, GA 30912, USA
    Expert Opin Pharmacother 12:411-34. 2011
    ....
  37. ncbi request reprint Reflections on leadership as chair of a department of psychiatry
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augusta, GA 30912, USA
    Acad Psychiatry 30:309-14. 2006
    ..The continued need to be a knowledgeable leader in the national trends of education, research, and clinical systems of care is a real challenge...
  38. ncbi request reprint Understanding and treating "first-episode" schizophrenia
    Peter J Weiden
    Department of Psychiatry, University of Illinois Medical Center, Chicago, IL, USA
    Psychiatr Clin North Am 30:481-510. 2007
    ..Clinicians and treatment services should try to identify "first-episode" patients in time to be able to anticipate and address these issues...
  39. ncbi request reprint Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications
    Peter J Weiden
    Department of Psychiatry, State University of New York SUNY Downstate Medical Center, Brooklyn, NY, USA
    J Clin Psychiatry 68:14-23. 2007
    ..The authors explain how to evaluate the specific side effect in the context of the current medication and the overall management of the patient...
  40. ncbi request reprint The art and science of switching antipsychotic medications, part 2
    Peter J Weiden
    Department of Psychiatry, Schizophrenia Research Program, State University of New York Downstate Medical Center and Kings County Hospital Center, Brooklyn, USA
    J Clin Psychiatry 68:e02. 2007
    ....
  41. ncbi request reprint Treating movement disorders and akathisia as side effects of antipsychotic pharmacotherapy
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta, Georgia, USA
    J Clin Psychiatry 69:e14. 2008
    ..Switching from a typical to an atypical antipsychotic or between atypical antipsychotics involves considering a variety of factors relating to the patient, illness, medication, and the patient's environment...
  42. ncbi request reprint Prevalence and consequences of dual diagnosis
    Peter F Buckley
    Department of Psychiatry, Medical College of Georgia, Augusta, USA
    J Clin Psychiatry 67:e01. 2006
    ..Screening, assessment, and integrated treatment plans for dual diagnosis to address both the substance use disorder and the mental illness are strongly recommended...
  43. ncbi request reprint First-episode psychosis: a window of opportunity for best practices
    Peter F Buckley
    Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, GA, USA
    CNS Spectr 12:1-12; discussion 13-4; quiz 15-6. 2007
    ..The use of first- or second-generation antipsychotics for psychosis treatment, dosing guidelines, and the antipsychotic side-effect profile will also be addressed...
  44. doi request reprint Immersing practitioners in the recovery model: an educational program evaluation
    Scott A Peebles
    Charlie Norwood Veterans Administration Medical Center, Augusta, GA, USA
    Community Ment Health J 45:239-45. 2009
    ..Findings generally supported the effectiveness of the intervention in increasing providers' knowledge of recovery and a shift in recovery-supporting attitudes...
  45. ncbi request reprint Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning
    David L Ginsberg
    Georgetown University School of Medicine, USA
    CNS Spectr 10:1-13; discussion 14-15. 2005
    ..Additionally, relative to older medications, atypicals have demonstrated benefit in improving some of the cognitive impairments...
  46. doi request reprint Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
    Bruce J Kinon
    Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, Indianapolis, IN 46285, USA
    J Clin Psychopharmacol 28:392-400. 2008
    ....
  47. ncbi request reprint Stimulus sequence affects schizophrenia-normal differences in event processing during an auditory oddball task
    Casey S Gilmore
    Department Psychology, University of Georgia, Psychology Building, Athens, GA 30602 3013, USA
    Brain Res Cogn Brain Res 24:215-27. 2005
    ..Thus, schizophrenia compromises the ability to properly use context to solve even simple cognitive problems...
  48. ncbi request reprint Update on the treatment and management of schizophrenia and bipolar disorder
    Peter F Buckley
    Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA
    CNS Spectr 13:1-10; quiz 11-2. 2008
    ..Research examining the pharmacology of commonly used medications for the treatment of both disorders is also presented...
  49. ncbi request reprint Dose response and atypical antipsychotics in schizophrenia
    Bruce J Kinon
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, Indianapolis, IN 46285, USA
    CNS Drugs 18:597-616. 2004
    ..Furthermore, the higher doses are not associated with a significantly increased incidence of adverse events. Further studies are clearly needed to fully characterise the dose-response relationships of atypical antipsychotics...
  50. ncbi request reprint Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment
    Douglas A Smith
    Northcoast Behavioral Healthcare, Northfield, OH, USA
    Behav Sci Law 24:351-67. 2006
    ..This article reviews the available literature that is specific to the treatment of delusional disorder. In addition, it focuses on specific forensic and medicolegal aspects of managing patients with delusional disorder...
  51. ncbi request reprint Rate of stimulation affects schizophrenia-normal differences on the N1 auditory-evoked potential
    Casey S Gilmore
    Department of Psychology, University of Georgia, Athens, GA 30602 3013, USA
    Neuroreport 15:2713-7. 2004
    ..These results suggest steady-state stimuli, up to a point, provide the extra information needed for schizophrenia patients to more efficiently integrate auditory information...
  52. ncbi request reprint Paradoxical reaction to fluoxetine
    Muhammad N Momen
    Psychosomatics 44:259-60. 2003
  53. ncbi request reprint Dosing equivalency of second-generation antipsychotic medications
    Peter F Buckley
    J Clin Psychopharmacol 25:501-2; discussion 502-4. 2005

Research Grants3

  1. Relapse Prevention: Long-Acting Atypical Antipsychotics
    Peter Buckley; Fiscal Year: 2007
    ..Even relatively modest delays in relapse and improvement of long term functioning potentially resulting from a long acting second-generation medication can translate into substantial public health benefits. ..